C12Y 103/01074
2-alkenal reductase
Official title: 2-Alkenal reductase (1.3.1.74)
C12Y103/01074 (2-alkenal reductase) appears on 1 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 4
- Assignees
- 4
- Inventors
- 7
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Recombinant host cells with improved production of tetraketide derivatives27 Aug 2026US 2026/0250728 A1Iptector Assets Aps
- Strain of Pseudomonas Putida Genetically Modified to Express a Benzalacetone Reductase23 Oct 2025US 2025/0327100 A1Bgene Genetics
- Recombinant host cells with improved production of tetraketide derivatives8 Aug 2024US 2024/0263203 A1Barrit Sarl
- Biosynthetic Mint6 Oct 2016US 2016/0289702 A1The University of Manchester
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.